These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 2549539)
1. Mutually exclusive use of viral promoters in Epstein-Barr virus latently infected lymphocytes. Woisetschlaeger M; Strominger JL; Speck SH Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6498-502. PubMed ID: 2549539 [TBL] [Abstract][Full Text] [Related]
2. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes. Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681 [TBL] [Abstract][Full Text] [Related]
3. Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. Woisetschlaeger M; Yandava CN; Furmanski LA; Strominger JL; Speck SH Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1725-9. PubMed ID: 2155423 [TBL] [Abstract][Full Text] [Related]
4. oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines. Puglielli MT; Woisetschlaeger M; Speck SH J Virol; 1996 Sep; 70(9):5758-68. PubMed ID: 8709191 [TBL] [Abstract][Full Text] [Related]
5. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype. Nilsson T; Sjöblom A; Masucci MG; Rymo L Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755 [TBL] [Abstract][Full Text] [Related]
6. B cell-specific activation of the Epstein-Barr virus-encoded C promoter compared with the wide-range activation of the W promoter. Contreras-Brodin B; Karlsson A; Nilsson T; Rymo L; Klein G J Gen Virol; 1996 Jun; 77 ( Pt 6)():1159-62. PubMed ID: 8683201 [TBL] [Abstract][Full Text] [Related]
7. The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated. Sample J; Henson EB; Sample C J Virol; 1992 Aug; 66(8):4654-61. PubMed ID: 1321268 [TBL] [Abstract][Full Text] [Related]
8. Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection. Woisetschlaeger M; Jin XW; Yandava CN; Furmanski LA; Strominger JL; Speck SH Proc Natl Acad Sci U S A; 1991 May; 88(9):3942-6. PubMed ID: 1850841 [TBL] [Abstract][Full Text] [Related]
9. Identification of a glucocorticoid-responsive element in Epstein-Barr virus. Kupfer SR; Summers WC J Virol; 1990 May; 64(5):1984-90. PubMed ID: 2157866 [TBL] [Abstract][Full Text] [Related]
10. Regulation of EBNA gene transcription in lymphoblastoid cell lines: characterization of sequences downstream of BCR2 (Cp). Puglielli MT; Desai N; Speck SH J Virol; 1997 Jan; 71(1):120-8. PubMed ID: 8985330 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the deletion and rearrangement in the BamHI C region of the X50-7 Epstein-Barr virus genome, a mutant viral strain which exhibits constitutive BamHI W promoter activity. Yandava CN; Speck SH J Virol; 1992 Sep; 66(9):5646-50. PubMed ID: 1323716 [TBL] [Abstract][Full Text] [Related]
12. Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines. Hutchings IA; Tierney RJ; Kelly GL; Stylianou J; Rickinson AB; Bell AI J Virol; 2006 Nov; 80(21):10700-11. PubMed ID: 16920819 [TBL] [Abstract][Full Text] [Related]
13. Repression of the viral latent promoter BC-R2 in Epstein-Barr virus negative cell lines. Klonjkowski B; Walls D; Gilardi-Hebenstreit P; Perricaudet M Biochem Biophys Res Commun; 1992 Dec; 189(3):1695-700. PubMed ID: 1336378 [TBL] [Abstract][Full Text] [Related]
14. Complex transcription of the Epstein-Barr virus BamHI fragment H rightward open reading frame 1 (BHRF1) in latently and lytically infected B lymphocytes. Austin PJ; Flemington E; Yandava CN; Strominger JL; Speck SH Proc Natl Acad Sci U S A; 1988 Jun; 85(11):3678-82. PubMed ID: 2836854 [TBL] [Abstract][Full Text] [Related]
15. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies. Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762 [TBL] [Abstract][Full Text] [Related]
16. Identification of a novel promoter located within the Bam HI Q region of the Epstein-Barr virus genome for the EBNA 1 gene. Tsai CN; Liu ST; Chang YS DNA Cell Biol; 1995 Sep; 14(9):767-76. PubMed ID: 7669254 [TBL] [Abstract][Full Text] [Related]
17. Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter. Jin XW; Speck SH J Virol; 1992 May; 66(5):2846-52. PubMed ID: 1313905 [TBL] [Abstract][Full Text] [Related]
18. Regulated expression of Epstein-Barr virus nuclear antigen 3-encoding gene carried on stable episomal vectors in human cells. James MR; Sarasin AR; Perricaudet M; Joab I Gene; 1990 Feb; 86(2):233-9. PubMed ID: 2157631 [TBL] [Abstract][Full Text] [Related]
19. Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1. Flemington E; Speck SH J Virol; 1990 Mar; 64(3):1217-26. PubMed ID: 2154605 [TBL] [Abstract][Full Text] [Related]
20. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Sample J; Brooks L; Sample C; Young L; Rowe M; Gregory C; Rickinson A; Kieff E Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6343-7. PubMed ID: 1648738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]